We are live on
!
Find out more
AR
Advisory Research Portfolio holdings
AUM
$813M
1-Year Est. Return
36.71%
This Fund
S&P 500
This Quarter
Est. Return
+31.97%
1 Year Est. Return
+36.71%
3 Year Est. Return
+123.04%
5 Year Est. Return
+262.63%
10 Year Est. Return
+840.35%
AUM
$1.12B
AUM Growth
-$319M
(-22%)
Cap. Flow
-$563M
Cap. Flow
% of AUM
-50.08%
Top 10 Holdings %
Top 10 Hldgs %
21.26%
Holding
360
New
82
Increased
64
Reduced
136
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$15.3M |
| 2 |
Broadridge
BR
|
+$13.9M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$11.1M |
| 4 |
Dominion Energy
D
|
+$10.6M |
| 5 |
NextEra Energy
NEE
|
+$9.11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CORE
Core Mark Holding Co., Inc.
CORE
|
+$34M |
| 2 |
Zurn Elkay Water Solutions
ZWS
|
+$26.8M |
| 3 |
Rio Tinto
RIO
|
+$26.3M |
| 4 |
TriMas Corp
TRS
|
+$23.6M |
| 5 |
Texas Instruments
TXN
|
+$23.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 17.12% |
| 2 | Technology | 14.48% |
| 3 | Financials | 14% |
| 4 | Industrials | 10.81% |
| 5 | Healthcare | 10.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMMU
251
DELISTED
Immunomedics Inc
IMMU
| $443K | 0.04% |
+12,494
| New | +$365K |
|
252
T. Rowe Price
TROW
$25B
| $438K | 0.04% |
3,548
+444
| +14% | +$50.6K |
|
253
Paylocity
PCTY
$6.71B
| $433K | 0.04% |
2,965
-11,160
| -79% | -$1.3M |
|
|
ZNGA
254
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $425K | 0.04% |
44,500
-179
| -0.4% | -$1.47K |
|
255
Constellation Brands
STZ
$22.2B
| $416K | 0.04% |
+2,376
| New | +$396K |
|
256
Apple
AAPL
$4.89T
| $405K | 0.04% |
4,440
-1,044
| -19% | -$80.9K |
|
257
Vanguard Intermediate-Term Treasury ETF
VGIT
$41.6B
| $403K | 0.04% |
5,712
| – | – |
|
258
Unilever
UL
$131B
| $402K | 0.04% |
6,504
-3,092
| -32% | -$185K |
|
|
SGI
259
Somnigroup International
SGI
$15.1B
| $402K | 0.04% |
22,364
+2,808
| +14% | +$40.3K |
|
260
Frontdoor
FTDR
$5.02B
| $400K | 0.04% |
+9,024
| New | +$368K |
|
261
MidCap Financial Investment
MFIC
$784M
| $394K | 0.04% |
41,207
-39,825
| -49% | -$360K |
|
262
Insulet
PODD
$11.3B
| $394K | 0.04% |
2,028
-677
| -25% | -$129K |
|
263
Sarepta Therapeutics
SRPT
$1.66B
| $394K | 0.04% |
+2,456
| New | +$334K |
|
|
ODP
264
DELISTED
ODP
ODP
| $392K | 0.03% |
+16,663
| New | +$363K |
|
265
TG Therapeutics
TGTX
$8.58B
| $386K | 0.03% |
+19,806
| New | +$319K |
|
|
AXON
266
Axon Enterprise
AXON
$40.5B
| $380K | 0.03% |
3,871
-20,706
| -84% | -$1.67M |
|
|
EXAS
267
DELISTED
Exact Sciences
EXAS
| $380K | 0.03% |
4,370
-1,598
| -27% | -$128K |
|
268
Best Buy
BBY
$18B
| $360K | 0.03% |
+4,123
| New | +$313K |
|
269
Lennar Class A
LEN
$20.4B
| $359K | 0.03% |
+6,010
| New | +$307K |
|
|
270
Rio Tinto
RIO
$148B
| $359K | 0.03% |
6,392
-518,554
| -99% | -$26.3M |
|
271
Altria Group
MO
$122B
| $349K | 0.03% |
8,880
| – | – |
|
272
Okta
OKTA
$24.1B
| $349K | 0.03% |
1,741
-891
| -34% | -$151K |
|
273
CrowdStrike
CRWD
$187B
| $346K | 0.03% |
13,812
-7,588
| -35% | -$152K |
|
274
Trex
TREX
$4.51B
| $345K | 0.03% |
5,306
-5,722
| -52% | -$305K |
|
275
Veeva Systems
VEEV
$30.3B
| $341K | 0.03% |
1,455
-567
| -28% | -$112K |
|
Similar funds
VFG
SLG
KCP
UAG
PS
CICI
RPAM
BBI
Advisory Research's Q2 2020 Portfolio in Review
As of Q2 2020, Advisory Research held 360 positions worth $1.12B, down 22% from $1.44B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Advisory Research withdrew a net $563M in Q2 2020, closing 54 positions and reducing 136 holdings. Its most notable exit was Chunghwa Telecom, an estimated $18.4M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, down from 18% a quarter earlier, followed by Technology and Financials.
Against the trend, Advisory Research opened a new position in AbbVie worth $17M.
- Advisory Research's largest Q2 2020 buy was AbbVie: 173,370 shares worth $17M.
- Advisory Research added most to Motorola Solutions in Q2 2020, an estimated $5.55M increase.
- Advisory Research's biggest Q2 2020 reduction was Core Mark Holding Co., Inc., cutting an estimated $34M.
- Advisory Research fully exited Chunghwa Telecom in Q2 2020, selling an estimated $18.4M.
- Advisory Research's ten largest holdings make up 21% of its $1.12B portfolio in Q2 2020.
- Advisory Research opened 82 new positions and closed 54 in Q2 2020.
- Advisory Research's portfolio value fell 22% quarter-over-quarter to $1.12B.
Based on Advisory Research's 13F filing for Q2 2020, filed 13 Aug 2020.